Skip to main content
          Skip to FDA Search
          Skip to in this section menu
          Skip to footer links


U.S. flagAn official website of the United States government

					Here’s how you know
          			Dot gov**The .gov means it’s official.**Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
							      SSL**The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. 
			U.S. Food and Drug Administration
				
        Search
            Menu
							
						Search FDA
									
									Submit search 
		Featured
							Contact FDA
	                FDA Guidance Documents
	                Recalls, Market Withdrawals and Safety Alerts
	                Press Announcements
	                Warning Letters
	                Advisory Committees
	                En Español

					Products
            Food
							Drugs
							Medical Devices
							Radiation-Emitting Products
							Vaccines, Blood, and Biologics
							Animal and Veterinary
							Cosmetics
							Tobacco ProductsTopics
            About FDA
							Combination Products
							Regulatory Information
							Safety
							Emergency Preparedness
							International Programs
							News and Events
							Training and Continuing Education
							Inspections and Compliance
							Science and ResearchInformation For
            Consumers
	            Patients
	            Industry
	            Health Professionals
	            Federal, State and Local Officials 
 In this section:

                Biologics Establishment Registration

Biologics Establishment Registration

                        Blood Establishment Registration and Product Listing
          Find a Blood Establishment
          Find a Tissue Establishment
          Human Cells, Tissues, and Cellular and Tissue-Based Products OMB Burden Statement
          Tissue Establishment Registration Home
          Vaccines, Blood & Biologics
          Guidance, Compliance & Regulatory Information (Biologics)
          Biologics Establishment Registration
          Tissue Establishment RegistrationBiologics Establishment Registration Tissue Establishment Registration
  
  	
    Subscribe to Email Updates
    Share
    Post
    Linkedin

    Email
    PrintEstablishments that manufacture human cells, tissues, and cellular and tissue-based products (HCT/Ps) regulated solely under section 361 of the Public Health Service (PHS) Act are required to register and list their HCT/Ps with the Food and Drug Administration (FDA) pursuant to 21 CFR part 1271. Establishments must register and list their HCT/Ps within 5 days of beginning operation and registration must be updated annually in December.

HCT/P establishments located outside of the United States (U.S.) that import, or offer for import, HCT/Ps into the U.S. are required to register with FDA. Foreign registrants must provide the information of their U.S. agent(s) and each importer that is known to the establishment. Other requirements for a foreign establishment’s registration and listing are described in §1271.25.

If the ownership or location of an HCT/P establishment changes, or if there is a change in the U.S. agent's name, address, telephone number, or email address, an amendment to registration must be submitted within 30 calendar days of the change. Establishments must amend their HCT/P listing if a change described in §1271.25(c)(1) through (4) has occurred. Such new information must be submitted at the time of change, or each June or December, whichever month occurs first.

FDA published in the Federal Register of August 31, 2016 (81 FR60170) a final rule that amended FDA’s regulations governing drug establishment registration and drug listing, including establishment registration and listing for HCT/Ps. Electronic submission of HCT/P establishment and product listing information is now required under §1271.22, unless waived in certain circumstances. HCT/P establishments that must register and list electronically under 21 CFR part 1271 should use the electronic HCT/P establishment registration system (eHCTERS) to meet the requirement for electronic submission of establishment registration and product listing. Establishments may request a waiver from the electronic submission requirement as described in §1271.23.

According to §1271.27(b), FDA acceptance of an establishment registration and HCT/P listing does not constitute a determination that an establishment is in compliance with applicable rules and regulations or that the HCT/P is licensed or approved by FDA.


Under the August 31, 2016 final rule, an establishment that manufactures HCT/Ps that are regulated as drugs, devices, and/or biological products under section 351 of the PHS Act and/or the Federal Food, Drug, and Cosmetic Act, must register and list their HCT/Ps following the procedures in 21 CFR part 207 or 807, as applicable, rather than 21 CFR part 1271.

FDA does not require establishments that manufacture HCT/Ps regulated as drugs, devices, and/or biological products that are the subject of an investigational new drug application (IND) (21 CFR part 312) or an investigational device exemption (IDE) (21 CFR part 812) to register and list those HCT/Ps in accordance with 21 CFR part 207 or 807 until the products receive marketing authorization.

Access to eHCTERS via CBER On-Line

CBER On-Line: Establishment Registration and Biological Product Deviation ReportingInstructions and Background Information

Instructions for Using the Electronic Human Cell and Tissue Establishment Registration System (eHCTERS)
	Requirements for Foreign and Domestic Establishment Registration and Listing for Human Drugs, Including Drugs That Are Regulated Under a Biologics License Application, and Animal Drugs; Final Rule 8/31/2016
	Human Cells, Tissues, and Cellular and Tissue-Based Products - CFR Correction
	1/18/2008
	Human Cells, Tissues, and Cellular and Tissue-Based Products; Establishment Registration and Listing; Correction
	2/4/2004
	Human Cells, Tissues, and Cellular and Tissue-Based Products; Establishment Registration and Listing
	1/27/2004
	Human Cells, Tissues, and Cellular and Tissue-Based Products; Establishment Registration and Listing
	1/21/2003
	Human Cells, Tissues, and Cellular and Tissue-Based Products; Establishment Registration and Listing
	1/19/2001Search for Information on Registered Human Cell and Tissue Establishments

Human Cell and Tissue Establishment Registration (HCTERS) Public Query Application

                                                                                  Content current as of:
      03/09/2021
              
              
Regulated Product(s)
		 Biologics
			  			     			  						              
			
			 
			  TissueTopic(s)
			  Application & ApprovalsBiologics Establishment Registration

          
                        Blood Establishment Registration and Product Listing
          Find a Blood Establishment
          Find a Tissue Establishment
          Human Cells, Tissues, and Cellular and Tissue-Based Products OMB Burden Statement
          Tissue Establishment Registration
 Subscribe for CBER Updates
                        Get e-mail updates on What’s New at CBER!
    Enter your email address to subscribe:
 Footer Links
    FDA Archive
          About FDA
          Accessibility
      Visitor Information
          Website Policies / Privacy
          No FEAR Act
          Vulnerability Disclosure Policy
      FOIA
          HHS.gov
          USA.gov
    Contact FDA
      Follow FDA on Facebook
      Follow FDA on X
      Follow FDA on Instagram
      Follow FDA on LinkedIn
      View FDA videos on YouTube
      Subscribe to FDA RSS feeds
    FDA Homepage
    Contact Number
      1-888-INFO-FDA (1-888-463-6332) Back toTop